1-3 of 3
Abraham Varghese
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria

CME Clinical Trials & Observations
Richard J. Kelly, Matthew Holt, Jennifer Vidler, Louise M. Arnold, Joanna Large, Briony Forrest, Catherine Barnfield, Alexandra Pike, Morag Griffin, Talha Munir, Petra Muus, Sateesh K. Nagumantry, Abraham Varghese, John R. Davies, Roochi Trikha, Austin G. Kulasekararaj, Lindsay Mitchell, Shreyans Gandhi
Journal: Blood
Blood (2024) 143 (12): 1157–1166.
https://doi.org/10.1182/blood.2023021762
Published: 2024
Journal Articles

Minimal residual disease is an independent predictor for 10-year survival in CLL

Clinical Trials & Observations Brief Report
Marwan Kwok, Andy C. Rawstron, Abraham Varghese, Paul A. S. Evans, Sheila J. M. O’Connor, Chi Doughty, Darren J. Newton, Paul Moreton, Peter Hillmen
Journal: Blood
Blood (2016) 128 (24): 2770–2773.
https://doi.org/10.1182/blood-2016-05-714162
Published: 2016
Includes: Supplemental data
Journal Articles

Minimal Residual Disease Is a Predictor for Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia (CLL) That Is Independent of the Type or Line of Therapy.

Marwan Kwok, MB, ChB, Andy C. Rawstron, PhD, Abraham Varghese, MB, ChB, MRCP, Peter Hillmen, MB, ChB, PhD
Journal: Blood
Blood (2009) 114 (22): 540.
https://doi.org/10.1182/blood.V114.22.540.540
Published: 2009